본문 바로가기
KERD
논문KCI 등재

Effects of Oral Procaterol for Postinfectious Cough in Adults: SingleCentre, Randomized Double-Blind, Placebo-Controlled Trial

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류가정의학

초록

Background: Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice. We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC). Methods: This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks. Results: Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks. Conclusion: Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.

Abstract

Background: Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice. We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC). Methods: This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks. Results: Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks. Conclusion: Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.

참고문헌 (30)

  1. Hegele RG, "Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections", Am J Respir Crit Care Med, 151, pp.1659~1664 (1995)
  2. Blair HT, "Effects of rhinovirus infection of pulmonary function of healthy human volunteers", Am Rev Respir Dis, 114, pp.95~102 (1976)
  3. Empey DW, "Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection", Am Rev Respir Dis, 113, pp.131~139 (1976)
  4. Borson DB, "Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections", J Appl Physiol (1985), 66, pp.2653~2658 (1989)
  5. Busse WW, "Effect of influenza A virus on leukocyte histamine release", J Allergy Clin Immunol, 71, pp.382~388 (1983)
  6. Chonmaitree T, "Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes:a possible role in the mechanism of virus-induced asthma", J Infect Dis, 164, pp.592~594 (1991)
  7. Ida S, "Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon", J Exp Med, 145, pp.892~906 (1977)
  8. Volovitz B, "Release of leukotriene C4 in respiratory tract during acute viral infection", J Pediatrw, 112, pp.218~222 (1988)
  9. O’Connell F, "Capsaicin cough sensitivity increases during upper respiratory infection", Respir Med, 90, pp.279~286 (1996)
  10. Salem H, "Antitussive drugs, with special reference to a new theory for the initation of the cough reflex and the influence or bronchodilators", Am J Med Sci, 247, pp.585~600 (1964)
  11. Hueston WJ, "A comparison of albuterol and erythromycin for the treatment of acute bronchitis", J Fam Pract, 33, pp.476~480 (1991)
  12. Frank A, "Inhaled beclomethasone dipropionate in acute infections of the respiratory tract", Respiration, 48, pp.122~126 (1985)
  13. Pornsuriyasak P, "Inhaled corticosteroid for persistent cough following upper respiratory tract infection", Respirology, 10, pp.520~524 (2005)
  14. Holmes PW, "Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection", Respir Med, 86, pp.425~429 (1992)
  15. Birring SS, "Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)", Thorax, 58, pp.339~343 (2003)
  16. Pornsuriyasak P, "Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough", Asian Pac J Allergy Immunol, 34, pp.212~216 (2016)
  17. Pornsuriyasak P, "Minimal clinically important differences (MCIDs) of the thai version of the leicester cough questionnaire for subacute and chronic cough", Value Health Reg Issues, 12, pp.57~62 (2017)
  18. Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999:this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
  19. Suzuki H, "Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan", United European Gastroenterol J, 1, pp.175~183 (2013)
  20. Jirarattanaphochai K, "Reliability of the medical outcomes study short-form survey version 2.0(Thai version) for the evaluation of low back pain patients", J Med Assoc Thai, 88, pp.1355~1361 (2005)
  21. Oostveen E, "The forced oscillation technique in clinical practice: methodology, recommendations and future developments", Eur Respir J, 22, pp.1026~1041 (2003)
  22. Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on the urge-to-cough sensation", Respir Med, 105, pp.615~618 (2011)
  23. Taramarcaz P, "Transient postviral vocal cord dysfunction", J Allergy Clin Immunol, 114, pp.1471~1472 (2004)
  24. Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on cough reflex sensitivity", J Thorac Dis, 6, pp.S708~S711 (2014)
  25. Tashimo H, "Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness", Allergol Int, 56, pp.241~247 (2007)
  26. Sekizawa K, "Role of substance P in cough during bronchoconstriction in awake guinea pigs", Am J Respir Crit Care Med, 151, pp.815~821 (1995)
  27. Fujimura M, "Effect of inhaled procaterol on cough receptor sensitivity to capsaicin in patients with asthma or chronic bronchitis and in normal subjects", Thorax, 48, pp.615~618 (1993)
  28. Tomerak AA, "Inhaled beta2-agonists for treating non-specific chronic cough in children", Cochrane Database Syst Rev, pp.CD005373~ (2005)
  29. Wang K, "Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis", Pediatr Infect Dis J, 30, pp.1047~1051 (2011)
  30. Ryan NM, "Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection", Respir Med, 106, pp.138~144 (2012)

관련 논문AI추천

Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough김주희, 박성훈, 장승훈, 정기석, 홍지영, 황용일대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제3호만성 난치성 기침에 대한 기침 억제 요법의 효과김지원, 박혜진, 유용준, 한명월대한후두음성언어의학회 · 대한후두음성언어의학회지2022 · 제33권 제1호Recent progress in the management of chronic cough송우정, Jin An, Lorcan McGarvey대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제4호Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough강민규, 권재우, 권혁수, 김경묵, 김민혜, 김상헌, 김상훈, 김세훈, 김철우, 문지용, 송우정, 이병재, 이상민, 이소희, 이진영, 임경환, 정재원, 조상헌, Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy an대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제5호HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study김도진, 이진국, Do Jin Kim, Jae Yeol Kim, Joo Hun Park, Myung Jae Park, Sang Won Yoon, Sang Yeub Lee대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제1호Efficacy and safety of HL-301 compared with erdosteine in acute bronchitis: a randomized, double-blind, non-inferiority trialChang Youl Lee, Chin Kook Rhee, Choi Joon Young, Deog Kyeom Kim, Hye Jung Park, Ji-Yong Moon, Kwang Ha Yoo, Kyung Hoon Min, Seong Yong Lim, Seung Won Ra, Yong Bum Park, M.D., Ph.D., Yong Il Hwang, Youlim Kim대한내과학회 · The Korean Journal of Internal Medicine2025 · 제40권 제5호

이 간행물의 다른 논문 (15건)